Rating History for Actuate Therapeutics (ACTU) by Rodman & Renshaw

More Stocks Rated by Rodman & Renshaw | Latest Ratings for ACTU
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
7/30/2026 Michael King Jr. New Coverage Buy
(N/A)		 6.00
(N/A)		 1.08
(1.54)		 42.59% Details